Celiac Disease

Discussing the latest advances in celiac disease

Share this:

Nov 10, 2013 · Leave a Reply

Larazotide Acetate & Celiac Disease

By Brent Westra @brentwestra

Note: This post was originally published on Mayo Clinic's Advancing the Science blog on April 17, 2013

Mayo Clinic gastroenterologist and celiac disease expert Joseph Murray, M.D., discusses a recent article published in Alimentary Pharmacology & Therapeutics that examined the effectiveness of larazotide acetate as an alternative treatment for celiac disease.

While he states that doesn't think that this drug, or other similar drugs, will be “a passport to eating gluten with impunity,” Dr. Murray is hopeful that they may reduce the sensitivity of a patient with celiac disease, which could allow for low-level gluten contamination without injury or symptoms.

For more information on celiac disease, visit: mayoclinic.org/celiac-disease

Tags: Alimentary Pharmacology & Therapeutics, Joseph Murray, larazotide acetate, Study Findings

Please login or become a member to post a comment.

Contact Us · Privacy Policy